Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
This guide compares region-focused ETFs to highlight which region pays the highest dividend and what factors influence payouts.
21,913 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Bank Of America upgrades TripAdvisor to Buy, signaling potential value from Viator and TheFork as Starboard Value exp...
Energy leaders convene amid a tightening mix of growth and risk. AI-driven demand and geopolitical tensions push pric...
In a high-stakes Senate hearing, Treasury Secretary Scott Bessent denies a looming $14 billion windfall for Iran from...
Zcash (ZEC) surged about 40% in a single session, reclaiming a spot among crypto's top names as privacy-focused coins...
New York Fed researchers find a widening gap in how households respond to rising gas prices after the Iran-related sh...
Retirement planning goes beyond a bank balance. This guide shows how to retire with confidence by aligning money, hea...
A former antitrust prosecutor who helped litigate the JetBlue-Spirit merger shares lessons for future airline regulat...
Analysts released a fresh batch of top calls on Thursday, reshaping sentiment across industrials and tech as earnings...
Disney beats Q2 expectations, sending Wall Street into a target-upgrade cycle. JPMorgan, Barclays and Guggenheim lift...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...
Bitcoin price falls below a crucial support level as traders weigh macro signals and rising leverage. The move raises...